Trevi Therapeutics (TRVI) Tops Q1 EPS by 4c
Trevi Therapeutics (NASDAQ: TRVI) reported Q1 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Trevi Therapeutics (NASDAQ: TRVI) reported Q1 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.